Steward Partners Investment Advisory, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 400 shares of LXRX stock, worth $204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$204
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LXRX
# of Institutions
137Shares Held
244MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$69.5 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$19.8 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$5.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$5.04 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$4.58 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $96.3M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...